-
Hemispherx BioPharma CEO Talks Stock Performance, Financials And Partnerships
Wednesday, January 4, 2017 - 11:45am | 599Hemispherx BioPharma, Inc (NYSE: HEB) is a nano-cap biopharmaceutical research and development company that focuses on the treatment of seriously debilitating disorders. Its flagship products include Alferon N Injection, Ampligen and Alferon LDO. Benzinga recently had the chance to speak with the...
-
Signs It's Time To Call In The Professionals On Your Finances
Sunday, August 21, 2016 - 9:11pm | 711There are so many ways you can handle your budget without calling in the big guns. However, whether you are not financially literate, don't seem to have the time/motivation or are so far removed from financial security that you don't even know where to start, using available resources such...